Seneca Biopharma Announces Presentations at Both Sachs Associates 3rd Annual Neuroscience Innovation Forum & Biotech Showcase™ 2020

On January 10, 2020 Seneca Biopharma, Inc., (NASDAQ: SNCA), a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, reported that Seneca’s Executive Chairman, Ken Carter, will present at both Sachs Associates 3rd Annual Neuroscience Innovation Forum, January 12, 2020 at the Marines Memorial Club, San Francisco, and Biotech Showcase 2020, being held January 13–15, 2020 at the Hilton San Francisco Union Square (Press release, Seneca Biopharma, JAN 10, 2020, View Source;biotech-showcase-2020-300984762.html [SID1234553000]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The details of Seneca’s presentations are as follows:

Event: Sachs Associates 3rd Annual Neuroscience Innovation Forum
Date: Sunday, January 12 2020
Time: 4:35 p.m. PST
Room: Room Heritage
Venue: Marines Memorial Club, San Francisco, CA (United States)

Event: Biotech Showcase
Date: Tuesday, January 14 2020
Time: 10:30 a.m. PST
Room: Franciscan A (Ballroom Level)
Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San
Francisco, CA (United States)

Sachs Associates 3rd Annual Neuroscience Innovation Forum, back for its 3rd annual edition, addresses through its conference programme the main challenges for 2020 in investment, partnering and alliance management. The program will cover BioPartnering for CNS, with industry keynotes and panels on AD, PD, Neuropsychiatry and Pain Management. Moreover, there are panels on innovation in neurotech covering banking, device, diagnostics and software.

Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry’s largest gatherings and busiest weeks.